Outlook Therapeutics, Inc. (OTLK)
Nasdaq: OTLK · Biological Products, (No Diagnostic Substances) · Iselin, NJ · filing with the SEC since 2015
Filings
478 filings since 2017 beside 270 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Dec 29, 2026
10-Q
Quarterly report for the quarter ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Feb 14, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 45 days after the quarter ended. The proxy statement was last filed Jun 1, 2026.
Filings a yearinsider forms included
8792756351796872
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Sep 30, 2026.Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Aug 27, 2026.SEC letters: 10 in the last 36 months, the newest Mar 26, 2025.A late-filing notice, Form NT 10-Q, filed Aug 17, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jul 16, 2026
8-K items 5.03, 5.07, 9.01
Charter, bylaw or fiscal-year change; Shareholder vote · Current report
May 13, 2026
8-K items 1.01, 1.02, 2.02, 9.01
Major agreement signed; Major agreement ended; Results released · Current report
May 12, 2026
Apr 23, 2026
8-K items 3.02, 8.01, 9.01
Shares sold without registration; Other event · Current report
Apr 22, 2026
40 of 478 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.